Article
Therapeutics for sickle cell disease intravascular hemolysis
13 Sept 2024
Abstract excerpt
Sickle cell disease (SCD) is a genetic disorder predominantly affecting individuals of African descent, with a significant global health burden. SCD is characterized by intravascular hemolysis, driven by the polymerization of mutated hemoglobin within red blood cells (RBCs), leading to vascular inflammation, organ damage, and heme toxicity. Clinical manifestations include acute pain crises, hemolytic anemia, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
